BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18058594)

  • 1. [Closure of patent foramen ovale in patients with cryptogenic stroke].
    Iwiński J; Białkowski J; Szkutnik M; Zembala M
    Kardiol Pol; 2007 Nov; 65(11):1403-5. PubMed ID: 18058594
    [No Abstract]   [Full Text] [Related]  

  • 2. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close.
    Messé SR; Kasner SE
    Circulation; 2008 Nov; 118(19):1999-2004. PubMed ID: 18981314
    [No Abstract]   [Full Text] [Related]  

  • 3. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else!
    Windecker S; Meier B
    Circulation; 2008 Nov; 118(19):1989-98. PubMed ID: 18981313
    [No Abstract]   [Full Text] [Related]  

  • 4. [Percutaneous closure of patent foramen ovale in young patients with cryptogenic stroke: long-term follow-up].
    Mazuelos F; Suárez de Lezo J; Pan M; Mesa D; Delgado M; Ruiz M; Ojeda S; Esteban F
    Rev Esp Cardiol; 2008 Jun; 61(6):640-3. PubMed ID: 18570787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    J Am Coll Cardiol; 2009 May; 53(21):2014-8. PubMed ID: 19460622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    Circulation; 2009 May; 119(20):2743-7. PubMed ID: 19433754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent foramen ovale and cryptogenic stroke: a complex neuro-cardio-vascular problem.
    Spies C; Wong M
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1455-67. PubMed ID: 19900028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patent foramen ovale: clinical manifestations and treatment.
    Kedia G; Tobis J; Lee MS
    Rev Cardiovasc Med; 2008; 9(3):168-73. PubMed ID: 18953276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent foramen ovale and cryptogenic stroke.
    Jaquis J
    Dimens Crit Care Nurs; 2007; 26(6):233-6. PubMed ID: 18090138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine, stroke and patent foramen ovale: a dangerous trio?
    Butera G; Agostoni E; Biondi-Zoccai G; Bresolin N; Fumagalli L; Chessa M; Gallanti A; Scacciatela P; Carminati M
    J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):233-8. PubMed ID: 18301138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous closure of patent foramen ovale and the risk of atrial fibrillation.
    Bhindi R
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):301; author reply 302. PubMed ID: 20049956
    [No Abstract]   [Full Text] [Related]  

  • 12. Cryptogenic stroke and patent foramen ovale.
    Thaler DE; Saver JL
    Curr Opin Cardiol; 2008 Nov; 23(6):537-44. PubMed ID: 18830067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
    Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
    Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
    Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptogenic stroke, aortic arch atheroma and patent foramen ovale.
    Molina CA; Santamarina E; Alvarez-Sabín J
    Cerebrovasc Dis; 2007; 24 Suppl 1():84-8. PubMed ID: 17971642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current evidence for closure of a patent foramen ovale for cryptogenic stroke prevention.
    Rhone E; Chung N; Clapp B
    Int J Clin Pract; 2014 May; 68(5):551-6. PubMed ID: 24373020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PFO closure failure with Amplatzer: a patient with concomitant multiple stroke risk factors.
    Sun X; Ellis J; Satler L; Hill PC
    J Card Surg; 2008; 23(5):576-8. PubMed ID: 18462339
    [No Abstract]   [Full Text] [Related]  

  • 18. [Migraine, stroke and patent foramen ovale--connected or not?].
    Vuković V; Aleksić-Shihabi A; Lovrencić-Huzjan A; Demarin V
    Acta Med Croatica; 2008 May; 62(2):197-203. PubMed ID: 18710084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Patent foramen ovale and cardiovascular stroke: the eternal dilemma].
    Stolfo D; Piazza R; Cassin M; Grandis U; Antonini-Canterin F; Pavan D; Nicolosi GL
    G Ital Cardiol (Rome); 2012; 13(7-8):474-89. PubMed ID: 22781374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PFO and stroke: what are the data?
    Wechsler LR
    Cardiol Rev; 2008; 16(1):53-7. PubMed ID: 18091402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.